No. of items: 281
Sorting after results
09/09/2021
Germany selected as site of WHO pandemic response hub
The World Health Organization (WHO) is locating a new center for responding to global pandemics in the German capital Berlin. Called the WHO Hub for Pandemic and Epidemic Intelligence, its main function will be to rapidly advise public health experts and policymakers around the globe when urgent …
31/08/2021
Record-breaking year for German medical biotechnology
The Boston Consulting Group (BCG) reports that Germany’s biopharmaceutical industry posted record market share and employment figures last year. The study also said sector turnovers were EUR 14.6 billion in 2020, an increase of 14 percent on 2019.
29/07/2021
Germany rapidly makes newly licensed drugs available
A study has found that German regulators are quickest at getting newly approved pharmaceuticals to patients. Industry observers say the speed is due to how the German healthcare system works.
12/07/2021
German government focuses support for COVID-19 therapies
Germany’s Federal Ministry of Education and Research (BMBF) has announced a grant of EUR 46 million for particularly promising approaches for treating COVID-19. The sum is the latest installment in an aid package amounting to at least EUR 90 million.
06/07/2021
Start-ups bring in investment for innovative cancer therapies
Two young German medical biotechnology companies are profiting from a rising investment trend. Analysts familiar with the industry say raised awareness of German medical biotech triggered by the success of COVID-19 vaccine-maker BioNTech is giving the sector a boost in general.
22/06/2021
DMEA wraps up presentation of latest in digital health
One of the world’s leading international trade shows for digital health technology, the DMEA - Connecting Digital Health, featured a week-long, virtual edition of the event, which ended on June 11. Organizers say more than 4,000 users registered this year, with an additional 2,500 people joining in …
14/06/2021
Beyond COVID-19: Leading mRNA drug innovation, production
Germany’s medical biotechnology industry met the challenge of COVID-19 with the BioNTech-Pfizer mRNA-based vaccine, one of the world’s first. Now, it is poised to develop other medications – such as cancer therapies – where mRNA could trigger a pharmaceutical revolution.
12/05/2021
German company making COVID vaccines for the world
IDT Biologika makes vaccines for leading drug manufacturers, including immunizations for COVID-19. AstraZeneca and Johnson & Johnson have commissioned the mid-sized contract research company in Dessau-Roßlau, Saxony-Anhalt, to make several million of doses their vector vaccines weekly.
26/04/2021
German government promotes COVID-19 drug development research
Germany’s Federal Ministry of Education and Research (BMBF) is supporting rapid development of drugs to treat patients with COVID-19. A grant program has earmarked EUR 50 million for drugs that are in clinical trials.
20/04/2021
Industry association reports Germany continues to be pharma innovator
The German chemical industry association, the Verband der Chemischen Industrie, VCI, has published figures showing Germany’s chemical and pharmaceutical industries are groundbreaking in terms of national and international research and development (R&D). The report shows that for some years now, the …
- Recommend this page:
- Print view